ITRM Insider Trading

Insider Ownership Percentage: 5.40%
Insider Buying (Last 12 Months): $91,500.00
Insider Selling (Last 12 Months): $0.00

Iterum Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Iterum Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Iterum Therapeutics Share Price & Price History

Current Price: $1.48
Price Change: Price Decrease of -0.09 (-5.73%)
As of 04/16/2024 02:24 PM ET

This chart shows the closing price history over time for ITRM up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Iterum Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/22/2023Michael W DunneDirectorBuy25,000$1.40$35,000.00113,754View SEC Filing Icon  
11/22/2023Michael W DunneDirectorBuy20,000$2.03$40,600.0078,754View SEC Filing Icon  
11/20/2023Corey N FishmanCEOBuy10,000$1.59$15,900.0054,449View SEC Filing Icon  
12/2/2022Sailaja PuttaguntaInsiderSell3,365$1.32$4,441.804,969View SEC Filing Icon  
9/19/2022Brenton Karl AhrensDirectorSell15,000$1.77$26,550.007,246View SEC Filing Icon  
9/16/2022Brenton Karl AhrensDirectorSell15,000$1.90$28,500.0022,246View SEC Filing Icon  
9/14/2022Brenton Karl AhrensDirectorSell15,000$2.10$31,500.0052,246View SEC Filing Icon  
9/12/2022Brenton Karl AhrensDirectorSell15,000$2.31$34,650.0082,246View SEC Filing Icon  
9/9/2022Brenton Karl AhrensDirectorSell15,000$2.32$34,800.0097,246View SEC Filing Icon  
9/7/2022Michael W DunneDirectorBuy10,000$2.22$22,200.0035,576View SEC Filing Icon  
3/14/2022Judith M MatthewsCFOSell47,132$0.38$17,910.16View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Iterum Therapeutics (NASDAQ:ITRM)

9.21% of Iterum Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ITRM by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Iterum Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/4/2023Apollon Wealth Management LLC200,000$0.21M0.0%N/A1.542%Search for SEC Filing on Google Icon
11/14/2022Renaissance Technologies LLC34,684$56K0.0%-89.3%0.284%Search for SEC Filing on Google Icon
11/10/2022New Leaf Venture Partners L.L.C.97,084$0.16M0.1%-93.3%0.794%Search for SEC Filing on Google Icon
11/10/2022Dimensional Fund Advisors LP62,301$0.10M0.0%N/A0.509%Search for SEC Filing on Google Icon
10/6/2022Krilogy Financial LLC20,000$32K0.0%-90.0%0.163%Search for SEC Filing on Google Icon
8/18/2022Goldman Sachs Group Inc.304,684$61K0.0%N/A0.166%Search for SEC Filing on Google Icon
8/13/2022Renaissance Technologies LLC323,300$65K0.0%+199.1%0.176%Search for SEC Filing on Google Icon
8/12/2022Franklin Resources Inc.258,778$52K0.0%-32.6%0.141%Search for SEC Filing on Google Icon
7/14/2022Krilogy Financial LLC200,000$40K0.0%N/A0.109%Search for SEC Filing on Google Icon
5/17/2022Virtu Financial LLC282,841$100K0.0%-32.4%0.155%Search for SEC Filing on Google Icon
11/16/2021Squarepoint Ops LLC52,503$29K0.0%+106.9%0.029%Search for SEC Filing on Google Icon
11/15/2021Franklin Resources Inc.384,200$0.22M0.0%N/A0.210%Search for SEC Filing on Google Icon
11/12/2021Renaissance Technologies LLC644,567$0.36M0.0%-80.4%0.353%Search for SEC Filing on Google Icon
10/25/2021Krilogy Financial LLC81,000$45K0.0%+161.3%0.044%Search for SEC Filing on Google Icon
9/17/2021Virtu Financial LLC83,658$0.19M0.0%-37.2%0.046%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC2,560,381$5.91M0.0%+3,304.5%1.429%Search for SEC Filing on Google Icon
8/16/2021Squarepoint Ops LLC25,382$59K0.0%-49.4%0.014%Search for SEC Filing on Google Icon
8/16/2021Cubist Systematic Strategies LLC89,431$0.21M0.0%N/A0.050%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC3,289,300$7.60M0.0%N/A1.836%Search for SEC Filing on Google Icon
8/13/2021Sigma Planning Corp17,153$40K0.0%N/A0.010%Search for SEC Filing on Google Icon
8/13/2021QS Investors LLC384,200$0.89M0.0%N/A0.214%Search for SEC Filing on Google Icon
8/12/2021Insight Advisors LLC PA35,000$28K0.0%-88.5%0.020%Search for SEC Filing on Google Icon
8/11/2021Susquehanna Fundamental Investments LLC66,230$0.15M0.0%N/A0.037%Search for SEC Filing on Google Icon
8/10/2021National Asset Management Inc.32,100$75K0.0%-61.0%0.018%Search for SEC Filing on Google Icon
8/4/2021Grimes & Company Inc.146,278$0.34M0.0%+17.4%0.082%Search for SEC Filing on Google Icon
7/15/2021Focused Wealth Management Inc100,000$0.23M0.0%+33.3%0.056%Search for SEC Filing on Google Icon
5/21/2021Citadel Advisors LLC137,026$0.19M0.0%-14.5%0.076%Search for SEC Filing on Google Icon
5/19/2021Virtu Financial LLC133,197$0.19M0.0%+209.0%0.074%Search for SEC Filing on Google Icon
5/19/2021Squarepoint Ops LLC50,196$71K0.0%N/A0.028%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC75,206$0.11M0.0%N/A0.042%Search for SEC Filing on Google Icon
5/18/2021Verition Fund Management LLC112,500$0.16M0.0%N/A0.063%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC137,026$0.19M0.0%-14.5%0.076%Search for SEC Filing on Google Icon
5/18/2021Jane Street Group LLC18,041$25K0.0%N/A0.010%Search for SEC Filing on Google Icon
5/17/2021Royal Bank of Canada19,000$27K0.0%N/A0.011%Search for SEC Filing on Google Icon
5/17/2021Edmond DE Rothschild Holding S.A.100,000$0.14M0.0%N/A0.056%Search for SEC Filing on Google Icon
5/17/2021HRT Financial LP399,479$0.56M0.0%+3,875.3%0.223%Search for SEC Filing on Google Icon
5/13/2021Barclays PLC50,000$71K0.0%N/A0.028%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC96,173$0.14M0.0%+190.4%0.054%Search for SEC Filing on Google Icon
5/12/2021Grimes & Company Inc.124,637$0.18M0.0%+73.1%0.070%Search for SEC Filing on Google Icon
5/12/2021FineMark National Bank & Trust300,000$0.42M0.0%N/A0.167%Search for SEC Filing on Google Icon
5/12/2021UBS Group AG52,961$75K0.0%N/A0.030%Search for SEC Filing on Google Icon
5/4/2021Commonwealth Equity Services LLC18,500$26K0.0%N/A0.010%Search for SEC Filing on Google Icon
2/25/2021Clear Street Markets LLC55,000$54K0.0%N/A0.045%Search for SEC Filing on Google Icon
2/24/2021Virtu Financial LLC43,111$43K0.0%N/A0.036%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC732,900$0.73M0.0%N/A1.493%Search for SEC Filing on Google Icon
2/9/2021Pivotal bioVenture Partners Investment Advisor LLC945,085$0.94M0.3%N/A1.926%Search for SEC Filing on Google Icon
2/3/2021Focused Wealth Management Inc75,000$74K0.0%N/A0.153%Search for SEC Filing on Google Icon
2/2/2021Grimes & Company Inc.72,000$71K0.0%N/A0.147%Search for SEC Filing on Google Icon
5/12/2020Granahan Investment Management Inc. MA241,121$0.65M0.0%-1.4%1.672%Search for SEC Filing on Google Icon
5/11/2020Ensign Peak Advisors Inc189,853$0.52M0.0%-17.7%1.317%Search for SEC Filing on Google Icon
5/1/2020UBS Group AG12,492$34K0.0%+542.3%0.089%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Iterum Therapeutics logo
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.
Read More on Iterum Therapeutics

Today's Range

Now: $1.48
Low: $1.45
High: $1.55

50 Day Range

MA: $1.52
Low: $1.24
High: $1.87

52 Week Range

Now: $1.48
Low: $0.62
High: $2.50

Volume

148,808 shs

Average Volume

542,309 shs

Market Capitalization

$24.32 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.36

Who are the company insiders with the largest holdings of Iterum Therapeutics?

Iterum Therapeutics' top insider investors include:
  1. Michael W Dunne (Director)
  2. Brenton Karl Ahrens (Director)
  3. Corey N Fishman (CEO)
  4. Sailaja Puttagunta (Insider)
Learn More about top insider investors at Iterum Therapeutics.